Point-of-care biosensor systems for cancer diagnostics/prognostics

Published in:

Biosensors & Bioelectronics 21,10 (2006) 1932-1942;


With the growing number of fatalities resulting from the 100 or so cancer-related diseases, new enabling tools are required to provide extensive molecular profiles of patients to guide the clinician in making viable diagnosis and prognosis. Unfortunately with cancer-related diseases, there is not one molecular marker that can provide sufficient information to assist the clinician in making effective prognoses or even diagnoses. Indeed, large panels of markers must typically be evaluated that cut across several different classes (mutations in certain gene fragments-DNA; over/underexpression of gene activity as monitored by messenger RNAs; the amount of proteins present in serum or circulating tumor cells). The classical biosensor format (dipstick approach for monitoring the presence of a single element) is viewed as a valuable tool in many bioassays, but possesses numerous limitations in cancer due primarily to the single element nature of these sensing platforms. As such, if biosensors are to become valuable tools in the arsenal of the clinician to manage cancer patients, new formats are required. This review seeks to provide an overview of the current thinking on molecular profiling for diagnosis and prognosis of cancers and also, provide insight into the current state-of-the-art in the biosensor field and new strategies that must be considered to bring this important technology into the cancer field. (c) 2006 Elsevier B.V. All rights reserved.


biosensors;; cancer;; point-of-care;; quartz-crystal-microbalance;; polymerase-chain-reaction;; label-free detection;; resonance imaging measurements;; phage-displayed library;; acoustic-wave sensor;; nanoimprint lithography;; piezoelectric biosensor;; microfluidic chips;; poly(methyl methacrylate)

Date of this Version

January 2006

This document is currently not available here.